Principales publications communes PDF Imprimer Envoyer
Écrit par Administrator   
Lundi, 05 Juillet 2010 12:46
  • Abalain, M. L., O. Petsaris, et al. (2010). "Fatal congenital tuberculosis due to a Beijing strain in a premature neonate." J Med Microbiol 59(Pt 6): 733-735.
  • Ben Yaghlene, H., I. Leguerinel, et al. (2009). "A new predictive dynamic model describing the effect of the ambient temperature and the convective heat transfer coefficient on bacterial growth." Int J Food Microbiol 133(1-2): 48-61.
  • Buhe, V., T. Guerrier, et al. (2009). "CpG ODN enhances the efficacy of rituximab in non-Hodgkin lymphoma." Ann N Y Acad Sci 1173: 858-864.
  • Buhe, V., J. O. Pers, et al. (2010). "Development of a Murine model to dissect the CpG-oligonucleotide-enhancement of the killing of human B Cells by rituximab." J Autoimmun 34(2): 136-144.
  • Cheze-Le Rest, C., J. P. Metges, et al. (2008). "Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study." Nucl Med Commun 29(7): 628-635.
  • De Braekeleer, E., A. Basinko, et al. (2010). "Cytogenetics in pre-B and B-cell acute lymphoblastic leukemia: a study of 208 patients diagnosed between 1981 and 2008." Cancer Genet Cytogenet 200(1): 8-15.
  • De Braekeleer, E., N. Douet-Guilbert, et al. (2010). "Distinct clonal anomalies involving RUNX1 in acute myeloid leukemia at diagnosis and after bone marrow transplantation." Ann Hematol.
  • De Braekeleer, E., N. Douet-Guilbert, et al. (2010). "Philadelphia chromosome-positive acute lymphoblastic leukemia: a cytogenetic study of 33 patients diagnosed between 1981 and 2008." Anticancer Res 30(2):569-573.
  • De Braekeleer, E., N. Douet-Guilbert, et al. (2010). "RUNX1 amplification in B-cell acute lymphoblasticleukemia." Leuk Lymphoma 51(2): 329-332.
  • De Braekeleer, E., J. C. Ianotto, et al. (2009). "A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene." Blood Cells Mol Dis 42(3): 292-293.
  • De Braekeleer, E., C. Meyer, et al. (2010). "Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature." Blood Cells Mol Dis 44(4):268-274.
  • De Braekeleer, E., C. Meyer, et al. (2010). "Identification of a MLL-MLLT4 fusion gene resulting from a t(6;11)(q27;q23) presenting as a del(11q) in a child with T-cell acute lymphoblastic leukemia." LeukLymphoma 51(8): 1570-1573.
  • Delluc, A., L. Gourhant, et al. (2010). "Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study." Thromb Haemost 103(6): 1161-1169.
  • Douet-Guilbert, N., J. Andrieux, et al. (2009). "Isoderivative of deleted chromosome 20 in primary myelofibrosis (PMF) characterized by molecular cytogenetics and array CGH." Ann Hematol 88(11): 1157-1159.
  • Douet-Guilbert, N., A. Basinko, et al. (2008). "Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions." Ann Hematol 87(7): 537-544.
  • Fraix, A., M. Lutz, et al. (2010). "Construction of a monoanionic S,N,S-pincer ligand with a pyrrole core by sequential [1,2] phospho-Fries rearrangement. Characterization of palladium and silver coordination complexes." Dalton Trans 39(11): 2942-2946.
  • Garaud, S., C. Le Dantec, et al. (2009). "IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation." J Immunol 182(9): 5623-5632.
  • Hammadi, M., J. O. Pers, et al. (2010). "A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency." Onco Targets Ther 3: 99-109.
  • Hatt, M., C. Cheze-Le Rest, et al. (2010). "Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements." J Nucl Med 51(9): 1368-1376.
  • Herry, A., N. Douet-Guilbert, et al. (2010). "Isochromosome 5p and related anomalies: a novel recurrent chromosome abnormality in myeloid disorders." Cancer Genet Cytogenet 200(2): 134-139.
  • Jamet, D., D. Quinio, et al. (2009). "[Systemic microsporidiosis and toxoplasmosis in a patient with T prolymphocytic leukemia]." Med Mal Infect 39(6): 406-408.
  • Le Gall, C., J. C. Ianotto, et al. (2008). "Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera." Leuk Res 32(5): 743-754.
  • Le Gall, T., I. Baussanne, et al. (2009). "Synthesis and transfection properties of a series of lipidic neamine derivatives." Bioconjug Chem 20(11): 2032-2046.
  • Le Mevel, J. C., F. Lancien, et al. (2009). "Central hyperventilatory action of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss." Gen Comp Endocrinol 164(1): 51-60.
  • Le Mevel, J. C., F. Lancien, et al. (2009). "Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout." J Exp Biol 212(Pt 23): 3919-3927.
  • Le Pottier, L., B. Bendaoud, et al. (2009). "New ELISA for B cell-activating factor." Clin Chem 55(10): 1843-1851.
  • Legrand-Abravanel, F., P. Colson, et al. (2009). "Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy." J Med Virol 81(12): 2029-2035.
  • Mankai, A., V. Buhe, et al. (2009). "Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1." Ann N Y Acad Sci 1173: 721-728.
  • Mimassi, N., F. Lancien, et al. (2009). "Central and peripheral cardiovascular effects of angiotensin III in trout." Ann N Y Acad Sci 1163: 469-471.
  • Mounier, J., G. Le Blay, et al. (2010). "Application of denaturing high-performance liquid chromatography (DHPLC) for yeasts identification in red smear cheese surfaces." Lett Appl Microbiol 51(1): 18-23.
  • Pasquier, E., C. Bohec, et al. (2009). "Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study." J Thromb Haemost 7(2): 306-311.
  • Petsaris, O., J. B. Nousbaum, et al. (2010). "Non-O1, non-O139 Vibrio cholerae bacteraemia in a cirrhotic patient." J Med Microbiol 59(Pt 10): 1260-1262.
  • Renaudineau, Y. (2010). "The revolution of epigenetics in the field of autoimmunity." Clin Rev Allergy Immunol 39(1): 1-2.
  • Renaudineau, Y., V. Devauchelle-Pensec, et al. (2009). "Monoclonal anti-CD20 antibodies: mechanisms of action and monitoring of biological effects." Joint Bone Spine 76(5): 458-463.
  • Renaudineau, Y., S. Garaud, et al. (2010). "Autoreactive B cells and epigenetics." Clin Rev Allergy Immunol 39(1): 85-94.
  • Rochas, C., S. Hillion, et al. (2009). "Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes." Arthritis Rheum 60(5): 1261-1271.
  • Salaun, P. Y., F. Couturaud, et al. (2010). "Non-invasive diagnosis of pulmonary embolism." Chest.
  • Salaun, P. Y., T. Gastinne, et al. (2009). "Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?" Eur J Nucl Med Mol Imaging 36(11): 1813-1821.
  • Salaun, P. Y., A. Le Duc-Pennec, et al. (2008). "Management of suspected pulmonary embolism patients with low clinical and low V/Q probability." Thromb Res 122(4): 450-454.
  • Sarandi, F., E. Hindie, et al. (2008). "[Use of fluorine-18-FDG PET-CT scans in initial management and follow-up of patients with cutaneous melanoma]." Ann Dermatol Venereol 135(10): 691-699.
  • Saraux, A. (2010). "The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjogren's syndrome." Autoimmun Rev 9(9): 609-614.
  • Tempescul, A., J. Feuerbach, et al. (2009). "A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia." Ann Hematol 88(1): 85-88.
  • Tempescul, A., J. C. Ianotto, et al. (2008). "High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children." Ann Hematol 87(6): 503-504.
  • Tempescul, A., J. C. Ianotto, et al. (2009). "Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma." Ann Hematol 88(9): 921-922.
  • Tempescul, A., S. Querellou, et al. (2010). "18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract." Ann Hematol 89(6): 635-637.
  • Teyton, P., J. P. Metges, et al. (2009). "Use of positron emission tomography in surgery follow-up of esophageal cancer." J Gastrointest Surg 13(3): 451-458.
  • Tobon, G. J., J. O. Pers, et al. (2010). "B cell-targeted therapies in Sjogren's syndrome." Autoimmun Rev 9(4): 224-228.
  • Tobon, G. J., Y. Renaudineau, et al. (2010). "The FMS-like tyrosine kinase3-ligand, a mediator for B cell survival is also a marker for lymphoma in primary Sjogren's syndrome." Arthritis Rheum.
  • Tobon, G. J., P. Youinou, et al. (2010). "The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis." J Autoimmun 35(1): 10-14.
  • Ugo, V., G. Le Gal, et al. (2008). "Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism." J Thromb Haemost 6(1): 203-205.
  • Youinou, P., V. Devauchelle-Pensec, et al. (2010). "Significance of B cells and B cell clonality in Sjogren's syndrome." Arthritis Rheum 62(9): 2605-2610.
Mise à jour le Lundi, 04 Avril 2011 15:17
 
UBOCHU Brest CNRS Inserm EFS
Ifremer ENIB Telecom Bretagne